| Age (yrs) |
56 ± 9 |
| Sex (M:F) |
26:4 |
| Ethnicity (Caucasian: Asian) |
29:1 |
| BMI |
29 ± 6 |
| Risk Factors [No (%)] |
|
| Smoking |
16 (53) |
| Hypertension |
11 (37) |
| Diabetes |
3 (10) |
| Family history |
9 (30) |
| Hyperlipidemia |
11 (37) |
| Troponin I (12 hours post PCI) (mg / mL) |
40 ± 16 |
| Pain to balloon time (mins) |
253 ± 150 |
| Door to balloon Time (mins)[median (interquartiles)] |
44 (30; 62) |
| Culprit coronary artery [No (%)] |
|
| LAD |
15 (50) |
| LCx |
2 (6) |
| RCA |
13 (43) |
| Number of vessels diseased [No (%)]
|
|
| 1 |
20 (67) |
| 2 |
6 (20) |
| 3 |
4 (13) |
| TIMI FLOW pre PCI [No (%)]
|
0.6 ± 1 |
| 0 |
21 (70) |
| 1 |
3 (10) |
| 2 |
4 (13) |
| 3 |
2 (6) |
| TIMI FLOW post PCI [No (%)] |
2.5 ± 0.6 |
| 0 |
0 |
| 1 |
2 (6) |
| 2 |
10 (33) |
| 3 |
18 (60) |
| Medications during PCI [No (%)] |
|
| GP IIb/IIIa inhibitor |
23 (76) |
| Clopidogrel |
30 (100) |
| Heparin |
28 (90) |
| Aspirin |
30 (100) |
| Concomitant medications on admission [No (%)] |
|
| Beta-blockers |
1 (3) |
| Ace-inhibitors |
6 (20) |
| Statins |
4 (13) |
| Medications post infarct |
|
| Beta-blockers |
28 (93) |
| Ace-inhibitors |
30 (100) |
| Statins |
30 (100) |
| Aspirin |
30 (100) |
| Diuretic |
3 (10) |
| Nitrates |
8 (27) |
